ERCC4 and Cowden syndrome 1: While mutations in XPF are not expected to specifically affect TC‐NER, because it acts downstream in the NER pathway where the transcription‐coupled and global NER pathways have come together, a CS phenotype has been observed previously in patients with mutations in XPF (Kashiyama et al, 2013).